31 December 2003
Brain Death Associated Ischemia/Reperfusion Injury
Johann Pratschke, Stefan Tullius, Peter NeuhausAnn Transplant 2004; 9(1): 78-80 :: ID: 8011
Abstract
I/R is an important non-immunological, antigen independent factor influencing graft outcome. In addition to its non-specific effects it potentiates graft immunogenicity and increases host alloresponsiveness. Originally considered an event surrounding organ procurement, preservation and revascularization, it has recently been associated with donor conditions such as brain death and the non-heart-beating donor. Occurring early in the transplant process, it initiates a cascade of molecular and cellular events including the release of proinflammatory mediators and attraction of various cell types infiltrating the tissues. As a consequence, acute and chronic changes develop which influence structure and function of the organ which may contribute to reduced graft survival. Eventually, attentuation of I/R by strategies interfering with the different processes promoted by this insult may constitute a means to improve both short and long-term graft outcome.
In Press
Original article
Biopsychosocial Effects of Donor Traits on Heart Transplant RecipientsAnn Transplant In Press; DOI:
Clinical Research
Ten-Year Retrospective Analysis of Continuous Renal Replacement Therapy in Burn Patients: Impact on Surviva...Ann Transplant In Press; DOI:
Original article
Factors Influencing Stress Disorders in Intensive Care Unit (ICU) Patients After Liver Transplantation: A C...Ann Transplant In Press; DOI: 10.12659/AOT.944320
Original article
Hepatopulmonary Syndrome and Liver Transplantation: Impact on Survival and Postoperative ComplicationsAnn Transplant In Press; DOI: 10.12659/AOT.945297
Most Viewed Current Articles
05 Apr 2022 : Original article 13,115
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,262
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,616
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,277
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860